Access And Retention In Metastatic Colorectal Cancer Trials

In the landscape of metastatic colorectal cancer clinical trials, the hurdles to participation extend far beyond the biology of the disease. Patients often navigate a demanding intersection of advanced disease burden, fluctuating gastrointestinal symptoms, and the physical toll of frequent treatment cycles. When specialized trial sites require long-distance travel, the logistical strain frequently leads to missed visits or early withdrawal, jeopardizing both the patient's access to care and the integrity of the study data.

True clinical trial success in this space requires a shift from passive observation to active logistical support. Evidence shows that when logistics are tailored to the patient’s stamina and symptom volatility, retention rates can improve by nearly 14 percentage points, with a 44% reduction in discontinuations. This overview explores how Scout utilizes integrated coordination to transform the trial experience for patients and sites alike.